Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis - A long-term follow-up

Sahin A., Bozkurt B., Irkec M.

CORNEA, vol.27, no.2, pp.193-195, 2008 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 2
  • Publication Date: 2008
  • Doi Number: 10.1097/ico.0b013e318033bd25
  • Journal Name: CORNEA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.193-195
  • Hacettepe University Affiliated: Yes

Abstract

Purpose: To report the efficacy of topical cyclosporine A (CsA) 0.05% drops (Restasis; Allergan, Irvine, CA) in the treatment of superior limbic keratoconjunctivitis (SLK).